TYME TECHNOLOGIES, INC. AND [●], Trustees INDENTURE Dated as of [__________], 20[__]Indenture • July 21st, 2016 • Tyme Technologies, Inc. • Pharmaceutical preparations • New York
THIS INDENTURE, dated as of [_____], 2016, between TYME TECHNOLOGIES, INC., a Delaware corporation (the “Issuer”), and [•], a national banking association organized and existing under the laws of the United States (the “Trustee”),
WARRANT TO PURCHASE COMMON STOCK OF TYME TECHNOLOGIES, INC.Warrant to Purchase Common Stock • July 21st, 2016 • Tyme Technologies, Inc. • Pharmaceutical preparations
This certifies that, for value received, ___________ or its registered assigns (“Holder”) is entitled, subject to the terms and conditions set forth below, to purchase from Tyme Technologies, Inc. (the “Company”), in whole or in part ___________ fully paid and nonassessable shares (the “Warrant Shares”) of common stock, par value $0.0001 per share (“Common Stock”), of the Company, at a purchase price of $___________ per Warrant Share (the “Exercise Price”). The number, character and Exercise Price of such shares of Common Stock are subject to adjustment as provided below and all references to “Warrant Shares” and “Exercise Price” herein shall be deemed to include any such adjustment or series of adjustments. The term “Warrant” as used herein shall mean this Warrant, and any warrants delivered in substitution or exchange therefor as provided herein.
